Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €3.13 EUR
Change Today 0.00 / 0.00%
Volume 18.6K
SSI On Other Exchanges
EN Paris
As of 11:35 AM 11/26/15 All times are local (Market data is delayed by at least 15 minutes).

supersonic imagine sa (SSI) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/8/14 - €9.03
52 Week Low
10/8/15 - €2.98
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SUPERSONIC IMAGINE SA (SSI)

Related News

No related news articles were found.

supersonic imagine sa (SSI) Related Businessweek News

No Related Businessweek News Found

supersonic imagine sa (SSI) Details

SuperSonic Imagine SA operates as a medical imaging company. The company develops the Aixplorer, an ultrasound system used in various applications, such as general imaging, women’s healthcare, vascular, hepatology/gastroenterology, and research. The company sells its products through a direct sales force and a distribution network in approximately 50 countries worldwide. SuperSonic Imagine SA was founded in 2005 and is headquartered in Aix-en-Provence, France.

149 Employees
Last Reported Date: 04/29/15
Founded in 2005

supersonic imagine sa (SSI) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: €100.4K
Co-Founder, Chief Strategic & Innovation Offi...
Total Annual Compensation: €269.0K
Co-Founder, Chief Technology Officer, Executi...
Total Annual Compensation: €229.7K
Chief Business Officer and Executive Vice Pre...
Total Annual Compensation: €302.1K
Compensation as of Fiscal Year 2014.

supersonic imagine sa (SSI) Key Developments

SuperSonic Imagine Reports Sales Results for the Third Quarter and Nine Months Ended September 30, 2015

SuperSonic Imagine reported sales results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported sales were EUR 5,199,000 against EUR 4,429,000 a year ago. For the nine months, the company reported total revenue was EUR 14,728,000 against EUR 13,644,000 a year ago.

SuperSonic Imagine Introduces Breakthrough Ultrasensitive Microvascular Imaging Technology

SuperSonic Imagine announced the introduction of breakthrough ultrasensitive microvascular imaging technology at the 63rd Journées Françaises de Radiologie (JFR), which will take place in Paris October 16 – 19, 2015. Already the pioneers of ShearWave Elastography, the company now introduced the next wave in ultrasound innovation – AngioPLUS – PLanewave UltraSensitive imaging. AngioPLUS is a significant advancement in Color Doppler Imaging. Conventional Doppler is limited in its ability to show microvascular slow flow. AngioPLUS significantly improves color sensitivity and spatial resolution, resulting in the next level of microvascular imaging to visualize flows that couldn’t be seen before. Soon available on Aixplorer, this innovation will provide highly detailed real-time information to physicians, which is key in diagnosing cancerous lesions. Lesion microvascularization and vessel flow are important indicators of a potential malignancy in areas such as breast, lymph nodes, thyroid and liver. This technique is also valuable for musculoskeletal assessments to help identify low-grade tendon inflammation. This innovation is possible to the unique UltraFast software platform of Aixplorer that can acquire images 200 times faster than conventional ultrasound systems. The flow of microvessels is very slow and challenging to image with conventional platforms. With its ability to help physicians see more detailed images, AngioPLUS could help minimize the use of intravenously administered contrast imaging agents currently used to improve sensitivity and resolution to image microvessels. In addition to liver and renal applications as quoted by Prof. Correas, AngioPLUS has demonstrated superb microvascular structures in the thyroid, breast, lymph nodes and in musculoskeletal applications detailing inflammation. The UltraFast platform is the foundation of two additional breakthrough innovations which have changed the paradigm of ultrasound imaging: ShearWave Elastography and UltraFast Doppler. ShearWave Elastography is used to assess and quantify tissue stiffness, an important parameter in diagnosing potentially malignant tissue. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians exam results simultaneously and helping increase patient throughput. This latest innovation, AngioPLUS, is a significant advancement to the 'arsenal' of non-invasive diagnostic tools for cancer diagnosis.

SuperSonic Imagine Announces Executive Changes

SuperSonic Imagine announced that appointment of Dr. Hermann Requardt, former Chief Executive Officer of Siemens Healthcare, as Chairman of its Supervisory Board. Dr. Requardt has been serving as an independent strategic advisor to the Supervisory Board since May 2015 and will, as expected, replace Mr. Bernard Doorenbos, who has been Acting Chairman since May 2015. Mr. Doorenbos will continue as a member of the Supervisory Board. Dr. Requardt is an Honorary Professor of Physics at the Goethe University in Frankfurt and serves on several academic and industrial boards. He most recently served as Chief Executive Officer of Siemens Healthcare from 2009 to February 2015. Prior to that, he was Chief Technology Officer of Siemens AG since 2008.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SSI:FP €3.13 EUR 0.00

SSI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SSI.
View Industry Companies

Industry Analysis


Industry Average

Valuation SSI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.2x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SUPERSONIC IMAGINE SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at